Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -1.36 (-4.08%)
Bid:
32.12
Ask:
32.22
Spread: 0.10 (0.311%)
Market Cap: £507.79m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Q3 2024 Trading Statement

10 Oct 2024 16:50

RNS Number : 7653H
THG PLC
10 October 2024
 

10 October 2024

 

 

THG PLC

Third quarter trading statement for the period ended 30 September 2024

 

Continuing Q3 revenue of £433.1m (-0.6% CCY)

 

Growth in Beauty and Ingenuity with improving trends in Nutrition through the quarter

 

Full-year performance expected to be within the company consensus range

 

Submission of THG's notification to the FCA for inclusion in the Equity Shares (Commercial Companies) ("ESCC") category

 

 

 

Q3 2024 Group Trading Performance

 

£m

Q3

2024

YoY[1]

change

CCY[2]

change

YTD2024

YoYchange

CCYchange

THG Beauty

254.7

+2.3%

+2.8%

775.0

+5.2%

+7.3%

THG Nutrition

134.5

-13.1%

-10.5%

434.3

-11.6%

-7.4%

THG Ingenuity (external)

44.0

+15.0%

+16.0%

124.2

+13.5%

+16.0%

Group (continuing) revenue

433.1

-2.0%

-0.6%

1,333.5

-0.3%

+2.7%

Discontinued revenue

9.7

-61.3%

-61.0%

43.3

-56.2%

-55.3%

Total revenue

442.8

-5.2%

-3.9%

1,376.8

-4.1%

-1.3%

THG Ingenuity (internal)

98.9

-15.7%

-15.7%

324.6

-11.4%

-11.4%

THG Ingenuity total

142.9

-8.2%

-8.0%

448.7

-5.7%

-5.2%

 

 

All comparative figures are continuing CCY unless otherwise stated.

 

· Continued growth in THG Beauty and THG Ingenuity (external), with improving trends in THG Nutrition during the quarter.

 

· Solid performance in THG Beauty as it builds to peak trading with advent calendar order run rate materially higher YoY.

 

Performance in the UK (over half of online Beauty revenue) was notably strong with active customers in growth (+5%).

Lookfantastic also launched its first flagship retail store as part of its targeted omnichannel strategy to enhance brand awareness, customer appeal and aid product discovery.

 

· Nutrition YoY revenue performance improved each month through the quarter.

 

o Sales have recovered from July and improved steadily through the quarter as the effect from the Myprotein rebrand fades, with September marking the second-best sales performance of the year, finishing the month in online growth excluding Asia.

Offline revenue growth of +17% in the quarter supports our expectations of c.25% of total brand sales coming from offline channels over the medium-term.

The transitionary impact from the rebrand is now behind Myprotein.

Licencing highlights include the launch of co-branded Müller dairy products in major UK and Ireland supermarkets in September, with a complete nutrition ready-to-drink product also available later this month.

 

· THG Ingenuity external revenue growth driven by existing and new partnerships mainly within fulfilment and courier management services.

 

Monthly recurring revenue[3] for THG Ingenuity (external) continued to build in September at +44.9% YoY, an acceleration on September 2023 (+7.6% YoY).

Onboarding of CDS Superstores (trading as wilko and The Range) and MySale complete with first dispatches in the quarter. Delivery options have already been expanded for both clients enhancing their customer proposition.

Fulfilment efficiency is expected to improve further for peak trading this year with the addition of Goods-To-Person robotics at the Group's Omega distribution centre enabling faster dispatch times.

 

· As part of the Group's ongoing portfolio management to further streamline all three businesses and optimise margin and cash generation, certain THG Beauty territories and non-core services were discontinued during Q3. Please refer to the appendix for the previous quarter comparatives.

 

 

ESCC transfer

 

· The Company's initial notification and eligibility letter for transfer to the ESCC category has been submitted to the FCA (1st October 2024). The Company continues to target effecting the transfer this calendar year and to be included in the FTSE UK Index reclassification in March 2025.

 

 

Outlook and guidance

 

· As noted in THG's Interim Results published on 17 September 2024, the second half of the year remains the Group's most profitable and cash generative period with the Board expecting full-year performance to be within the company consensus range[4].

 

· Seasonal weighting and continued revenue growth in Beauty and Ingenuity gives us confidence in the outturn, albeit we continue to monitor FX movements (Japanese Yen c.£7m ytd impact) and rising whey prices.

 

 

 

Matthew Moulding, CEO of THG commented:

 

"Today we have separately announced significant progress on our strategy to demerge THG Ingenuity into a private company supported by major shareholders. THG PLC will remain a listed leading consumer brands group, with our planned transfer to the ESCC well on track.

 

"It was especially pleasing to see another solid quarter of delivery from both our Beauty and Ingenuity businesses, rewarding the significant overhaul of their respective operating models during 2022 and 2023. The short-term disruption from the major rebrand of Myprotein is now behind us, and we were pleased that in September Nutrition delivered its best sales performance since January.

 

"We are also proud to be recognised in the top 250 companies worldwide for our contribution and efforts in sustainability thanks to our ongoing progress towards our net zero goals.

 

"Preparations for our busiest trading period are well advanced with efficiencies across the network over the last twelve months delivering further benefits for our Ingenuity clients to aid new customer acquisition."

 

 

 

Analyst and Institutional investor conference call

 

THG will host a conference call for analysts and institutional investors at 9:30am 11th of October (UK time) via the following link:

 

https://stream.brrmedia.co.uk/broadcast/67068e9c5c401b3f38830f49

 

To ask questions, you must dial in via conference line using the below details:

 

· Confirmation password: THG Q3

· UK dial in: +44 (0) 33 0551 0200

· US dial in: +1 786 697 3501

 

 

For further information please contact:

 

Investor enquiries - THG PLC

 

Greg Feehely, SVP Investor Relations

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

 

 

Media enquiries:

 

Sodali & Co - Financial PR adviser

Tel: +44 (0) 20 7250 1446

 

Victoria Palmer-Moore / Russ Lynch

thg@sodali.com

 

 

THG PLC

Viki Tahmasebi

 

 

 

 

 

 

 

Viki.tahmasebi@thg.com

 

APPENDIX

 

Quarterly reported revenue growth rates

 

Q1 2023

Q2 2023

Q3 2023

Q4 2023

FY 2023

Q1 2024

Q2 2024

Q3 2024

YTD 2024

THG Beauty

-9.8%

-8.3%

-1.6%

+1.4%

-4.1%

+11.4%

+2.6%

+2.3%

+5.2%

THG Nutrition

+5.7%

+1.8%

-3.8%

-6.0%

-0.7%

-9.0%

-12.8%

-13.1%

-11.6%

THG Ingenuity

-14.3%

-15.4%

-8.8%

-5.8%

-11.0%

-5.3%

-3.6%

-8.2%

-5.7%

Inter-group elimination

-15.5%

-17.1%

-10.5%

-9.0%

-13.0%

-8.0%

10.6%

-15.7%

-11.4%

Group (continuing) revenue

-4.4%

-4.9%

-2.5%

-0.5%

-2.9%

+2.9%

-1.6%

-2.0%

-0.3%

Other (discontinued)

-38.1%

-48.5%

-60.1%

-53.0%

-50.0%

-54.8%

54.1%

-61.3%

-56.2%

Group revenue

-8.3%

-10.3%

-9.5%

-6.9%

-8.7%

-2.0%

-5.2%

-5.2%

-4.1%

Memo: External Ingenuity

-10.1%

-8.6%

-2.9%

+7.1%

-3.5%

+4.1%

+21.2%

+15.0%

+13.5%

 

 

 Quarterly constant currency revenue growth rates

 

Q1 2023

Q2 2023

Q3 2023

Q4 2023

FY 2023

Q1 2024

Q2 2024

Q3 2024

YTD 2024

THG Beauty

-12.9%

-8.5%

0.9%

+3.2%

-3.9%

+13.2%

+3.2%

+2.8%

+7.3%

THG Nutrition

+3.8%

+2.0%

-1.4%

-4.0%

0.0%

-5.8%

-9.2%

-10.5%

-7.4%

THG Ingenuity

-14.7%

-15.4%

-8.5%

-5.4%

-10.9%

-4.9%

-3.5%

-8.0%

-5.2%

Inter-group elimination

-15.5%

-17.1%

-10.5%

-9.0%

-13.0%

-8.0%

-10.6%

-15.7%

-11.4%

Group (continuing) revenue

-7.1%

-5.0%

-0.1%

+1.5%

-2.5%

+5.3%

+0.2%

-0.6%

+2.7%

Other (discontinued)

-37.7%

-48.5%

-59.9%

-52.9%

-49.9%

-53.9%

-53.7%

-61.0%

-55.3%

Group revenue

-11.0%

-10.1%

-7.6%

-5.3%

-8.4%

+0.3%

-3.4%

-3.9%

-1.3%

Memo: External Ingenuity

-11.7%

-8.8%

-1.4%

+9.4%

-3.1%

+5.9%

+22.3%

+16.0%

+16.0%

 

 

Quarterly reported revenue

 

£m

Q1

2023

Q2

2023

Q3

2023

Q4

2023

FY

2023

Q1

2024

Q2

2024

Q3

2024

YTD

2024

THG Beauty

227.9

259.6

249.0

360.3

1,096.9

253.9

266.3

254.7

775.0

THG Nutrition

165.7

171.0

154.8

166.4

657.9

150.8

149.0

134.5

434.3

THG Ingenuity (external)

35.6

35.6

38.2

44.6

154.0

37.0

43.2

44.0

124.2

Group (continuing) revenue

429.2

466.2

442.1

571.4

1,908.9

441.8

458.6

433.1

1,333.5

Discontinued revenue

40.1

33.7

25.0

37.6

136.5

18.2

15.5

9.7

43.3

Total revenue

469.4

499.9

467.2

609.0

2,045.4

459.9

474.0

442.8

1,376.8

THG Ingenuity (internal)

122.3

126.5

117.4

153.6

519.9

112.6

113.0

98.9

324.6

THG Ingenuity total

157.9

162.1

155.7

198.2

673.9

149.6

156.2

142.9

448.7

 

 

Above numbers and table subject to rounding.

 

 

 

 

ENDS

 

Notes to editors

 

THG PLC operate three distinct businesses in Beauty, Nutrition and Ingenuity, each scaled from the UK to hold global leading positions in their respective sectors.

 

 

Cautionary Statement

Certain statements included within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation.

 

 


[1] YoY defined as year-on-year statutory sales growth

[2] CCY defined as constant currency basis

[3] Monthly Recurring Revenue comprises Software-as-a-Service license fees, managed service fees, revenue share, fulfilment and creative services

[4] Adjusted EBITDA range of £124.4m to £141.0m as dated 07.10.24 and available at Analyst Consensus - THG.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEBLFFZBLXFBK
Date   Source Headline
20th May 201310:19 amRNSNotice of Results
13th May 20137:00 amRNSCompletion of Foodstore Developments
28th Feb 20134:40 pmRNSResult of AGM
18th Feb 201310:31 amRNSDirector/PDMR Shareholding
12th Feb 201310:01 amRNSDirector/PDMR Shareholding
8th Feb 20134:44 pmRNSSale of Residential Portfolio
6th Feb 201310:23 amRNSDirector/PDMR Shareholding
4th Feb 20137:00 amRNSStudent accommodation forward funding and pre-sale
23rd Jan 20137:00 amRNSAnnual Financial Report and Notice of AGM
11th Dec 20127:00 amRNSFinal Results
30th Nov 20127:00 amRNSNotice of Results
14th Nov 20127:00 amRNS£30m Leisure Scheme Development in Darlington
29th Oct 20127:00 amRNSPre-sale of Southampton Development
28th Sep 20121:22 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSAcquisition of new foodstore development
10th Sep 20125:14 pmRNSCapital Reduction
2nd Aug 201211:20 amRNSResult of EGM
13th Jul 201210:26 amRNSCirc re. Reduction of Share Premium Account
14th Jun 20128:19 amRNSDirector/PDMR Shareholding
13th Jun 20128:07 amRNSDirector/PDMR Shareholding
12th Jun 20127:00 amRNSHalf Yearly Report
6th Jun 20123:20 pmRNSNotice of Results
8th May 20127:00 amRNSStrong Progress Across Foodstore Developments
5th Apr 201212:01 pmRNS£35m Forward Funding for Sainsbury's in Sunderland
30th Mar 20122:46 pmRNSDirector/PDMR Shareholding
27th Mar 201210:32 amRNSDirector/PDMR Shareholding
8th Mar 20125:16 pmRNSDirector/PDMR Shareholding
8th Mar 20122:25 pmRNSDirector/PDMR Shareholding
7th Mar 201212:37 pmRNSSale of Residential Portfolio for £75.35m
2nd Mar 201212:04 pmRNSResult of AGM - Replacement
2nd Mar 20127:00 amRNSLetting and Sale at Brabazon Office Park, Bristol
1st Mar 20123:42 pmRNSResult of AGM
17th Feb 20124:25 pmRNSDirector/PDMR Shareholding
13th Feb 20123:39 pmRNSResidential Update
7th Feb 20122:28 pmRNSAnnual Financial Report and Notice of AGM
30th Jan 20127:00 amRNSDevelopment Agreement with Sainsbury's
6th Jan 20127:00 amRNSFinal Results
3rd Jan 20122:15 pmRNSNotice of Results
15th Nov 20116:07 pmRNSClarification / Additional Disclosure
4th Nov 20117:00 amRNSMarketing of Residential Investment Business
20th Sep 20117:00 amRNSPlanning recommendation for foodstore
7th Sep 20117:00 amRNSPlanning recommendation for two foodstore schemes
30th Jun 20113:10 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSAcquisition of Foodstore Development Site
16th Jun 20111:25 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSAcquisitions
25th May 20113:08 pmRNSDirectorate Change
25th May 20117:00 amRNSHalf Yearly Report
23rd May 201112:16 pmRNSNotice of Results
19th May 20117:00 amRNSRe Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.